Europe API Market To Reach $80bn By 2033 – Study Predicts
The active pharma ingredient market in Europe has been a matter of much discussion, and no wonder it has laid a very exclusive but...
Research Leads To Major Advancements In Chemical Synthesis
Austria’s University of Vienna’s team of chemists, which happen to be led by Nuno Maulide, has gone on to achieve quite a prominent breakthrough...
$1.5bn Manufacturing Plant By AstraZeneca In Singapore Soon
On May 20, 2024, AstraZeneca, the global biopharma company, announced plans to build a $1.5 billion manufacturing facility in Singapore. With this announcement, the...
Growing Market Size – US Clinical Trials Supply & Logistics
As per a study conducted in May 2024, the US clinical trials supply and logistics market size was placed at $1.90 billion in 2023...
Robust Supply Chains Are Essential For Affordable Drugs
The Central Drugs Standard Control Organization (CDSCO), which happens to be India’s central regulatory body for pharmaceuticals, on April 30, 2024, went on to...
8 Essential Elements of Quality Management In Lab Practices
Given the intricacy of lab operations, manual management in terms of laboratory quality can indeed be very challenging. A cloud-based lab quality management system...
FDA Solidifies Its Authority Over Laboratory-Developed Tests
The FDA’s final rule that solidifies its presence and authority on Laboratory-Developed Tests- LDTs goes on to mark a prominent shift in the regulation...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...